Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,465 | 11,824 | 14,339 | 17,035 | 16,072 |
| Receivables | 236 | 261 | 135 | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 67 | 0 |
| TOTAL | $6,792 | $12,186 | $14,575 | $17,470 | $16,091 |
| Non-Current Assets | |||||
| PPE Net | 17,314 | 19,545 | 11,394 | 492 | N/A |
| Intangibles | 9,942 | 15,479 | 19,230 | 24,236 | N/A |
| TOTAL | $27,256 | $35,024 | $30,624 | $24,727 | $0 |
| Total Assets | $34,047 | $47,210 | $45,199 | $42,198 | $16,091 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 120 | 123 | 74 | 493 | 42 |
| Accrued Expenses | 30 | 99 | 66 | N/A | N/A |
| TOTAL | $151 | $248 | $183 | $833 | $79 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | -24 | 0 |
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $151 | $248 | $183 | $833 | $79 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 109,780 | 0 | 0 | 0 |
| Retained earnings | -65,920 | -66,005 | -48,159 | -29,647 | -9,542 |
| Other shareholders' equity | 1,798 | 3,186 | 2,578 | 802 | 156 |
| TOTAL | $33,896 | $46,962 | $45,016 | $41,341 | $16,012 |
| Total Liabilities And Equity | $34,047 | $47,210 | $45,199 | $42,174 | $16,091 |